市場調査レポート
商品コード
1451879
バイオテクノロジー試薬市場レポート:技術、用途、地域別、2024-2032Biotechnology Reagents Market Report by Technology (Life Science Reagents, Analytical Reagents), Application (Protein Synthesis and Purification, Gene Expression, DNA and RNA Analysis, Drug Testing, and Others), and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
バイオテクノロジー試薬市場レポート:技術、用途、地域別、2024-2032 |
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
|
世界のバイオテクノロジー試薬市場規模は、2023年に854億1,010万米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけての成長率(CAGR)は7.42%を示し、2032年には1,658億1,950万米ドルに達すると予測しています。ライフサイエンス分野における研究開発(R&D)活動の発展、個別化医療や標的治療に対する需要の高まり、ゲノミクスやプロテオミクス研究の急速な進展、慢性疾患や感染症の急増などが、市場を牽引する主な要因となっています。
バイオテクノロジー試薬は、ライフサイエンス分野で極めて重要な役割を果たし、様々な研究や診断アプリケーションを促進します。試薬は、生物学的分子やシステムの単離、分析、操作を可能にするバイオテクノロジー・プロセスで使用される重要なコンポーネントです。これらは細心の製造工程を経て製造され、正確で信頼性の高い結果を提供するよう設計されており、実験や調査の進展と成功を確実なものにしています。バイオテクノロジー試薬の主な利点のひとつは、その多用途性とライフサイエンスにおける複数の分野にわたる幅広い適用性です。バイオテクノロジー試薬は、デオキシリボ核酸(DNA)、リボ核酸(RNA)、タンパク質の抽出・精製、アッセイ、バイオマーカーの検出、遺伝子発現研究の実施を可能にするため、ゲノミクス、プロテオミクス、細胞生物学、分子診断学、創薬などの様々な研究分野で活用されています。バイオテクノロジー試薬はまた、新しい治療薬、ワクチン、個別化医薬品の開発を促進し、ヘルスケアと疾病治療の進歩に貢献しています。
世界のバイオテクノロジー試薬市場は、ライフサイエンス分野における研究開発(R&D)活動の増加や、個別化医療や標的治療に対する需要の高まりなど、数多くの要因によって支えられています。さらに、ゲノミクスやプロテオミクス研究の急速な進展、慢性疾患や感染症の急増が市場の成長を加速させています。このほか、バイオテクノロジーと分子生物学の技術的進歩、製薬・バイオテクノロジー産業の拡大も市場成長に弾みをつけています。さらに、ヘルスケア・インフラへの投資の急増、政府のイニシアティブ、研究プロジェクトへの資金提供なども成長を促す要因となっています。これに伴い、学術機関と業界各社との共同研究が活発化し、分子診断薬に対する認識と採用が高まっていることも、市場の成長を後押ししています。さらに、バイオインフォマティクスや計算生物学の台頭、バイオバンクやバイオリポジトリ施設の拡大も市場成長を後押ししています。その他、正確な実験結果を得るための高品質な試薬に対する需要の急増、農業における遺伝子組み換え作物(GMO)に対する需要の高まり、CRISPR/Cas9遺伝子編集などの新たな用途に向けた新規試薬の市場開拓などが、市場成長にプラスに寄与しています。
The global biotechnology reagents market size reached US$ 85,410.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 165,819.5 Million by 2032, exhibiting a growth rate (CAGR) of 7.42% during 2024-2032. Increasing research and development (R&D) activities in the life sciences sector, the growing demand for personalized medicine and targeted therapies, the rapid advancements in genomics and proteomics research, and the surging prevalence of chronic and infectious diseases represent some of the key factors driving the market.
Biotechnology reagents play a pivotal role in the field of life sciences, facilitating various research and diagnostic applications. They are vital components used in biotechnology processes to enable the isolation, analysis, and manipulation of biological molecules and systems. They are made through meticulous manufacturing processes and are designed to provide accurate and reliable results, ensuring the progress and success of experiments and investigations. One of the key advantages of biotechnology reagents is their versatility and broad applicability across multiple disciplines within the life sciences. They are utilized in various research areas, such as genomics, proteomics, cell biology, molecular diagnostics, and drug discovery, as they enable scientists to extract and purify deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins, as well as perform assays, detect biomarkers, and conduct gene expression studies. Biotechnology reagents also facilitate the development of new therapeutic drugs, vaccines, and personalized medicines, contributing to advancements in healthcare and the treatment of diseases.
The global biotechnology reagents market is bolstered by numerous factors, including the increasing research and development (R&D) activities in the life sciences sector and the growing demand for personalized medicine and targeted therapies. Moreover, the rapid advancements in genomics and proteomics research and the surging prevalence of chronic and infectious diseases are accelerating the market growth. Besides this, the technological advancements in biotechnology and molecular biology and the expansion of pharmaceutical and biotechnology industries are providing an impetus to the market growth. Additionally, the burgeoning investments in healthcare infrastructure and government initiatives and funding for research projects are other growth-inducing factors. In line with this, the escalating collaborations between academic institutions and industry players and growing awareness and adoption of molecular diagnostics are supporting the market growth. Furthermore, the emergence of bioinformatics and computational biology and the expansion of biobanking and biorepository facilities are augmenting the market growth. Other factors, such as the surging demand for high-quality reagents for accurate experimental results, escalating demand for genetically modified organisms (GMOs) in agriculture, and the development of novel reagents for emerging applications, such as CRISPR/Cas9 gene editing, are positively contributing to the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global biotechnology reagents market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on technology and application.
Life Science Reagents
PCR
Cell Culture
Hematology
In-Vitro Diagnostics
Others
Analytical Reagents
Chromatography
Mass Spectrometry
Electrophoresis
Flow Cytometry
Others
A detailed breakup and analysis of the biotechnology reagents market based on the technology has also been provided in the report. This includes life science reagents (PCR, cell culture, hematology, In-Vitro diagnostics, and others) and analytical reagents (chromatography, mass spectrometry, electrophoresis, flow cytometry, and others).
Protein Synthesis and Purification
Gene Expression
DNA and RNA Analysis
Drug Testing
Others
A detailed breakup and analysis of the biotechnology reagents market based on the application has also been provided in the report. This includes protein synthesis and purification, gene expression, DNA and RNA analysis, drug testing, and others.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for biotechnology reagents. Some of the factors driving the North America biotechnology reagents market included the surging applications of biotechnology in environmental monitoring and remediation, the development of novel reagents for emerging applications, such as CRISPR/Cas9 gene editing, and the expansion of the biotechnology industry.
The report has also provided a comprehensive analysis of the competitive landscape in the global biotechnology reagents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Lonza Group AG, Merck KGaA, Meridian Bioscience Inc. (SD Biosensor), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., and Waters Corporation etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.